General MedicationsINJECTIONGeneric
CEFTAZIDIME
CEFTAZIDIME
Standard Dose
6GM/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CEFTAZIDIME is listed in Drugs@FDA under application 065482 (ANDA).
Marketing status: Discontinued Active ingredient CEFTAZIDIME Form and strength INJECTABLE;INJECTION - 6GM/VIAL Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2010-05-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEFTAZIDIME is listed in Drugs@FDA under application 065482 (ANDA). Marketing status: Discontinued Active ingredient CEFTAZIDIME Form and strength INJECTABLE;INJECTION - 6GM/VIAL Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2010-05-28 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.